Treatment with hydrogen molecule attenuates cardiac dysfunction in streptozotocin-induced diabetic mice.

The publication “Treatment with hydrogen molecule attenuates cardiac dysfunction in streptozotocin-induced diabetic mice.” is organized in H2HUBB under the research focus hydrogen water cardiovascular health study 2015. The publication is cited as Wu F, Qiu Y, Ye G, Luo H, Jiang J, Yu F, Zhou W, Zhang S, Feng J, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology, 2015. This uncontrolled human study examined Treatment with hydrogen molecule attenuates cardiac dysfunction in streptozotocin-induced diabetic mice. The abstract describes Human participants; sample size 83; hydrogen delivered as hydrogen water and injected or infused hydrogen; reported duration 5 days. The abstract reports: Treatment with hydrogen molecule attenuated cardiac dysfunction in streptozotocin-induced diabetic mice, which was independent of glycemic control. This is an automated editorial draft based on the abstract and requires source review before publication.

Hydrogen water cardiovascular health study 2015 overview

The aim of present study was to investigate the therapeutic effect of hydrogen molecule on streptozotocin-induced diabetic cardiomyopathy in mice. Animal research can identify biological effects and support future investigation, but it cannot by itself establish safety or effectiveness in humans.

Study design and hydrogen intervention

Publication type: Animal study. Evidence type: Preclinical animal evidence. Research model or population: Mouse model. Sample size: 83. Blinding: Unknown. Control status: Unknown.

Delivery method: Hydrogen water. Hydrogen concentration: 0.2 mg/l. Dose or treatment amount: 50 mg. Treatment duration: 5 days.

Reported findings and scientific interpretation

For this hydrogen water cardiovascular health study 2015, the study record reports the following: The abstract reports: Treatment with hydrogen molecule attenuated cardiac dysfunction in streptozotocin-induced diabetic mice, which was independent of glycemic control.

These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.

How this research record was prepared

H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.

Limitations, safety, and original source

Limitations: The intervention or follow-up period appears relatively short.

Safety: The abstract did not provide detailed safety or adverse-event information.

This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.